Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
01/2009
01/14/2009EP2014650A1 Process and intermediate for the production of an intermediate in the production of montelukast
01/14/2009EP2013181A1 Pyridyl compounds
01/14/2009EP2013178A1 Piperazine derivatives as growth hormone secretagogue (ghs) receptor agonists
01/14/2009EP2013170A1 4-squarylpiperazine derivatives as antiviral agents
01/14/2009EP2012778A2 Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof
01/14/2009EP1874762B1 Method for the production of 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide
01/14/2009EP1751103B1 4-(5-(aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity
01/14/2009EP1567518B1 Oxime ester photoinitiators with heteroaromatic groups
01/14/2009EP1560584B1 Fab i inhibitors
01/14/2009EP1532120B1 Phenylpyridazine derivatives as ligands for gaba receptors
01/14/2009EP1478363B1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
01/14/2009EP1323716B1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells
01/14/2009EP1300396B1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof
01/14/2009CN101346369A Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions
01/14/2009CN101346353A Sulfonamide derivatives and use thereof for the modulation of metalloproteinases
01/14/2009CN101346349A Process for the production of ezetimibe and intermediates used in this proces
01/14/2009CN101346243A Optical recording medium and azacyanine dye
01/14/2009CN101346141A Quinoline derivatives useful in the treatment of MGLUR5 receptor-mediated disorders
01/14/2009CN101343251A Thrombopoietin mimetics
01/14/2009CN101343250A Thrombopoietin mimetics
01/14/2009CN101342169A Thrombopoietin mimetics
01/14/2009CN100451016C Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors
01/14/2009CN100451014C Process for making chiral 1,4-disubstituted piperazines
01/14/2009CN100450477C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
01/13/2009US7478376 Computer program code size partitioning method for multiple memory multi-processing systems
01/13/2009US7476746 PPAR active compounds
01/13/2009US7476741 Treating proliferative disorders such as cancer, autoimmune or inflammatory diseases such as psoriasis; e.g. 4-(3-Bromo-4,5-dimethoxyphenyl)-3-cyano-7-dimethylamino-4H-chromene; use with known anticancer drugs or radiotherapy
01/13/2009US7476727 Conjugates of mycophenolic acid
01/13/2009US7476690 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
01/13/2009US7476688 Cyclic amidine derivatives
01/13/2009US7476686 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea; viricides; Hepatitis C infection
01/13/2009US7476685 Pyridine carboxamide derivatives and their use as pesticides
01/13/2009US7476682 N-substituted piperidine derivatives as serotonin receptor agents
01/13/2009US7476680 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents
01/13/2009US7476675 Quinolinone derivatives and uses thereof
01/13/2009US7476673 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology
01/13/2009US7476664 Bis-2-difluoro-pyrrolo[2,1-C][1,4]benzodiazepine dimers
01/13/2009CA2216542C 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity
01/08/2009WO2009006580A1 Optionally condensed dihydropyridine, dihydropyrimidine and dihydropyrane derivatives acting as late sodium channel blockers
01/08/2009WO2009006413A1 Substituted pyrrolidines
01/08/2009WO2009005045A1 Substituted dihydroisoquinoline derivative
01/08/2009WO2009005024A1 Method for producing optically active amine
01/08/2009WO2009005002A1 Quinolone derivative
01/08/2009WO2009004383A2 Aza-bicyclohexane compounds useful as anticoagulants
01/08/2009WO2009004356A1 Phthalazinone derivatives as inhibitors of parp-1
01/08/2009WO2009003868A2 2 -imidazolines having a good affinity to the trace amine associated receptors (taars)
01/08/2009WO2009003861A1 Imidazole derivatives as ccr2 receptor antagonists
01/08/2009WO2008142720A3 Quinazolin-oxime derivatives as hsp90 inhibitors
01/08/2009WO2008141462A9 Novel case of renin inhibitors
01/08/2009WO2008128750A3 Process for the manufacture for non-steroidal anti-inflammatory agents and intermediates thereof
01/08/2009WO2008063548A3 5, 6, or 7-substituted-s- (hetero)arylisoquinolinamine derivatives as antitumor agents
01/08/2009WO2008057254A3 Tricyclic compounds as matrix metalloproteinase inhibitors
01/08/2009US20090012309 Chemical compounds
01/08/2009US20090012302 Method of isolating a nucleic acid using a material containing an amino group and a carboxyl group and positively charged at a first ph and a solid material for nucleic acid isolation used for the method
01/08/2009US20090012290 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors
01/08/2009US20090012148 Reducing cellular cholesterol levels and/or treating or preventing phospholipidosis
01/08/2009US20090012122 N-aroyl cyclic amine derivatives as orexin receptor antagonists
01/08/2009US20090012083 N-aroyl cyclic amine derivatives as orexin receptor antagonists
01/08/2009US20090012081 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells
01/08/2009US20090012073 N-aroyl cyclic amines
01/08/2009US20090012070 Pesticidal heterocycles
01/08/2009US20090012069 Novel Antidiabetic Compounds
01/08/2009DE102006014324B4 Inhibitoren der löslichen Adenylatzyklase Inhibitors of soluble adenylate cyclase
01/08/2009DE102006014319B4 Inhibitoren der löslichen Adenylatzyklase Inhibitors of soluble adenylate cyclase
01/08/2009CA2692145A1 Antiviral compounds
01/08/2009CA2691662A1 Imidazole derivatives as ccr2 receptor antagonists
01/08/2009CA2691459A1 Phthalazinone derivatives as inhibitors of parp-1
01/08/2009CA2691082A1 2 -imidazolines having a good affinity to the trace amine associated receptors (taars)
01/08/2009CA2689116A1 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof
01/07/2009EP2010527A1 1,5 and 3,6- substituted indole compounds having nos inhibitory activity
01/07/2009EP2010526A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands
01/07/2009EP2010521A1 Indazole compounds and methods for inhibition of cdc7
01/07/2009EP2010520A1 Fused phenyl amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases
01/07/2009EP2010519A2 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
01/07/2009EP2010515A1 2-(pyridin-2-yl)-pyrimidines for use as fungicides
01/07/2009EP2010514A1 3-(pyridin-2-yl)-[1,2,4]-triazines for use as fungicides
01/07/2009EP2010509A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers
01/07/2009EP2010506A1 Diazepan derivatives modulators of chemokine receptors
01/07/2009EP2010505A2 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
01/07/2009EP2010502A1 Pyrimidine derivatives for the treatment of amyloid-related diseases
01/07/2009EP2010485A1 Azetidine derivatives as g-protein coupled receptor (gpr119 ) agonists
01/07/2009EP2010289A2 Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol
01/07/2009EP1727799B1 Novel alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
01/07/2009EP1569916B1 Substituted aralkyl derivatives
01/07/2009EP1562589B1 Diaminotriazoles useful as inhibitors of protein kinases
01/07/2009EP1470113B1 Pyrimidinone viral polymerase inhibitors
01/07/2009EP1431285B1 Reverse hydroxamic acid derivatives
01/07/2009EP1392662B1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
01/07/2009EP1204665B1 Chemokine receptor antagonists and methods of use therefor
01/07/2009EP1001939B1 Heterocyclic substituted 4-benzoyl-pyrazole as herbicides
01/07/2009CN101341149A Chromane substituted benzimidazoles and their use as acid pump inhibitors
01/07/2009CN101341136A Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same
01/07/2009CN101341133A Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
01/07/2009CN101341131A Imidazoles as gaba-b receptor modulators
01/07/2009CN101341130A Imidazole derivatives for the treatment of gastrointestinal disorders
01/07/2009CN101341129A Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
01/07/2009CN101341128A Pyrazoles for the treatment of gerd and ibs
01/07/2009CN101341127A 4,5-dihydro- (1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators
01/07/2009CN101341126A Antibacterial active 5-chinolin derivative
01/07/2009CN101341123A 3-aminocyclopentanecarboxamides as modulators of chemokine receptors